Get the Stockscreener App
355.44
0.44%
-1.56
After Hours:
355.00
-0.44
-0.12%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Waters Corp stock is traded at $355.44, with a volume of 1.44M.
It is down -0.44% in the last 24 hours and up +7.00% over the past month.
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with BD's life science and diagnostics business, which increased its concentration in diagnostics (versus none now) and discovery-related life science tools.
See More
Previous Close:
$357.00
Open:
$358.97
24h Volume:
1.44M
Relative Volume:
1.40
Market Cap:
$34.90B
Revenue:
$3.77B
Net Income/Loss:
$449.25M
P/E Ratio:
45.25
EPS:
7.8556
Net Cash Flow:
$240.68M
1W Performance:
-1.20%
1M Performance:
+7.00%
6M Performance:
-5.55%
1Y Performance:
+4.74%
1-Day Range:
$353.56
$360.65
1-Week Range:
$351.77
$367.96
52-Week Range:
$275.05
$414.15
Waters Corp Stock (WAT) Company Profile
Name
Waters Corp
Sector
Industry
Phone
(508) 478-2000
Address
34 MAPLE ST, MILFORD, MA
Compare WAT vs TMO, DHR, IDXX, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WAT
Waters Corp
|
355.44 | 34.90B | 3.77B | 449.25M | 240.68M | 7.8556 |
TMO
Thermo Fisher Scientific Inc
|
464.61 | 172.66B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
177.17 | 125.40B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
562.09 | 44.34B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
127.06 | 35.89B | 7.23B | 1.41B | 1.09B | 4.979 |
Waters Corp Stock (WAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-06-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Feb-10-26 | Resumed | Barclays | Overweight |
| Feb-10-26 | Resumed | Citigroup | Buy |
| Feb-10-26 | Resumed | Evercore ISI | In-line |
| Jan-06-26 | Initiated | Guggenheim | Buy |
| Jan-05-26 | Initiated | William Blair | Outperform |
| Dec-10-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-02-25 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-08-25 | Initiated | Rothschild & Co Redburn | Buy |
| Mar-31-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-26-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-13-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Feb-10-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-10-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Oct-08-24 | Upgrade | Jefferies | Hold → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Aug-01-24 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Nov-13-23 | Downgrade | Barclays | Equal Weight → Underweight |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-31-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Jul-20-22 | Initiated | UBS | Neutral |
| May-18-22 | Initiated | Barclays | Overweight |
| May-17-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Apr-25-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Jul-06-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-07-21 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Dec-17-20 | Upgrade | Cleveland Research | Underperform → Buy |
| Dec-16-20 | Upgrade | Citigroup | Sell → Neutral |
| Dec-02-20 | Initiated | Goldman | Neutral |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jul-28-20 | Upgrade | JP Morgan | Underweight → Neutral |
| Jul-16-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Jan-08-20 | Downgrade | Needham | Hold → Underperform |
| Jan-08-20 | Initiated | Wells Fargo | Underweight |
| Jan-07-20 | Initiated | Citigroup | Sell |
| Nov-15-19 | Initiated | Stifel | Hold |
| Oct-09-19 | Downgrade | Barclays | Equal Weight → Underweight |
| Jul-16-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jun-12-19 | Downgrade | Cleveland Research | Neutral → Underperform |
| May-30-19 | Initiated | Wolfe Research | Underperform |
| Jan-24-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-03-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jan-03-19 | Initiated | Needham | Hold |
| Dec-12-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-30-18 | Downgrade | Goldman | Neutral → Sell |
| Oct-11-18 | Upgrade | Cleveland Research | Sell → Neutral |
View All
Waters Corp Stock (WAT) Latest News
Waters StockAnalyst consensus and sector context after Q1 beat - AD HOC NEWS
Smart workflows at the bench, Waters ACQUITY Arc Bio helps labs keep up - AD HOC NEWS
Subtle but forensic, Waters ACQUITY Premier UHPLC targets stubborn metals - AD HOC NEWS
Waters Corp (WAT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Waters Corp (WAT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Waters Corp (WAT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Waters Corporation Stock: Is WAT Underperforming the Health Care Sector? - Barchart.com
Waters Corp (NYSE:WAT) Technical Setup Signals High-Quality Breakout Opportunity - ChartMill
Waters Corp (WAT) Institutional Confidence - TradingKey
Waters Arc Premier System targets demanding labs with precision and uptime gains - AD HOC NEWS
Waters Corporation Stock (US9418481035): New product launches keep the stock in focus - AD HOC NEWS
Battery safety testing gets a sharper edge with Waters' Coin Cell DSC - AD HOC NEWS
Waters Corp. stock outperforms competitors on strong trading day - MSN
Waters Corporation Stock (US9418481035): Fundamentals and valuation under the microscope - AD HOC NEWS
Waters Launches New Tools As Investors Weigh Biologics And Battery Upside - Yahoo Finance
Waters Corp. stock outperforms competitors despite losses on the day - MarketWatch
Waters Corporation ACQUITY Premier System: UHPLC workhorse for demanding labs - AD HOC NEWS
Calvert U.S. Mid Cap Core Responsible Index Fund's Waters Corp(WAT) Holding History - GuruFocus
Abraham Fortress Fund's Waters Corp(WAT) Holding History - GuruFocus
Westchester Capital Management, Inc.'s Waters Corp(WAT) Holding History - GuruFocus
Top Waters (WAT) Competitors 2026 - MarketBeat
Waters targets earlier thermal runaway detection with whole-cell coin cell differential scanning calorimeter - R&D World
Piper Sandler initiates Waters stock coverage with neutral rating By Investing.com - Investing.com South Africa
Piper Sandler initiates Waters stock coverage with neutral rating - Investing.com
Waters Corporation Stock (US9418481035): New Coin Cell DSC Launch Puts Materials Analysis In Focus - AD HOC NEWS
Waters Company Profile & Introduction - Moomoo
Waters Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Waters launches coin cell calorimeter for battery testing - Investing.com
Waters Launches Coin Cell Differential Scanning Calorimeter (DSC) to Advance Battery Safety with Integrated Thermal, Evolved Gas, and Electrochemical Analysis - Yahoo Finance
Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis - Finviz
2026 Power 100: Udit Batra - Worcester Business Journal
What Just Happened with BD and Waters - Kavout
New Waters columns speed testing for GLP‑1, insulin and LNP drug substances - Stock Titan
Waters Corporation $WAT Shares Sold by Bank of New York Mellon Corp - MarketBeat
ETFs Investing in Waters Corporation Stocks - TradingView
Waters Corp. stock underperforms Friday when compared to competitors - MarketWatch
Waters Corporation stock (US9418481035): valuation metrics in focus after recent product news - AD HOC NEWS
Evercore ISI upgrades Waters stock rating on achievable targets - Investing.com
T. Rowe Price Capital Appreciation Fund's Waters Corp(WAT) Holding History - GuruFocus
Waters (WAT) Gains FDA Clearance for Automated Blood Culture Sys - GuruFocus
Waters Corp at Jefferies Global Healthcare Conference in New York Transcript - GuruFocus
Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics - Sharecast.com
Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics – Company Announcement - Financial Times
Kevin Hern acquires Waters Corporation stock through Hern Family Revocable Trust - Investing.com
10,716 Shares in Waters Corporation $WAT Bought by BW Gestao de Investimentos Ltda. - MarketBeat
FDA-cleared blood culture system flags sepsis infections 3 hours faster - Stock Titan
Waters Corp Coverage Assumed by Wolfe Research at Outperform - Moomoo
Wolfe Research initiates Waters stock with Outperform rating By Investing.com - Investing.com India
Waters Corp stock (US94106L1098): new mass spectrometry launch highlights innovation ahead of next e - AD HOC NEWS
Wolfe Research initiates Waters stock with Outperform rating - Investing.com UK
Waters Corporation stock (US9418481035): shares steady after May analyst updates and Q1 earnings - AD HOC NEWS
Waters Corp Stock (WAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.20%
1.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):